低能量冲击波治疗顽固性ⅢB型前列腺炎的临床分析  

Clinical analysis of typeⅢB chronic prostatitis with low-energy shock wave therapy

作　　者：朱小东 卞军 潘枫渝 杨昭倩 刘一帆[1] 何永忠[1] 欧海宁[2] 黄涛[2] 林家锡 ZHU Xiaodong;BIAN Jun;PAN Fengyu;YANG Zhaoqian;LIU Yifan;HE Yongzhong;OU Haining;HUANG Tao;LIN Jiaxi(Department of Urology,Fifth Affiliated Hospital of Guangzhou Medical University,Guangzhou,510700,China;Department of Rehabilitation Medicine,Fifth Affiliated Hospital of Guangzhou Medical University)

机构地区：[1]广州医科大学附属第五医院泌尿外科,广州510700 [2]广州医科大学附属第五医院康复医学科

出　　处：《临床泌尿外科杂志》2020年第10期771-773,777,共4页Journal of Clinical Urology

基　　金：广州市卫生健康科技项目(No:20201A011106,No:20191A011092);广东省医学科研基金项目(No:B2019113)。

摘　　要：目的:探讨低能量冲击波对顽固性ⅢB型前列腺炎的治疗效果,并分析其并发症、安全性。方法:选取2019年5月~2020年1月广州医科大学附属第五医院男科门诊的顽固性ⅢB型前列腺炎患者104例作为研究对象,随机平均分成两组,每组52例。研究组采用低能量冲击波治疗(每周1次,4周为1疗程)联合盐酸坦索罗辛缓释胶囊口服(0.2 mg,口服,每日睡前1次)治疗,对照组则仅采用盐酸坦索罗辛缓释胶囊口服治疗。治疗4周为1个疗程,1个疗程结束后采用前列腺炎症状评分(NIH-CPSI)表对临床症状进行评分,并分析其并发症、安全性。结果:1个疗程治疗结束后,研究组和对照组NIH-CPSI评分均有明显下降,但研究组NIH-CPSI评分下降的程度明显大于对照组,差异有统计学意义(P<0.05);另外研究组总有效率明显比对照组高(73.1%vs.34.6%),差异有统计学意义(P<0.05)。结果显示研究组治疗效果较对照组更好,两组患者治疗过程中均未发现明显不良反应及并发症。结论:低能量冲击波治疗联合常规药物治疗对顽固性ⅢB型前列腺炎疗效显著,治疗效果明显优于常规药物,显示低能量冲击波治疗可进一步改善顽固性ⅢB型前列腺炎治疗效果,安全性可靠,值得在临床上进一步推广。Objective:To evaluate the clinical efficacy and safety of low-energy shock wave therapy on typeⅢB chronic prostatitis.Method:From May 2019 to January 2020,104 patients with typeⅢB chronic prostatitis in the outpatient department of our hospital were selected as the research subjects,and they were randomly divided into two groups with 52 patients in each group.The study group was treated by low-energy shock wave therapy(once a week)combined with tamsulosin(0.2 mg/d)for 4 weeks,while the control group was treated with tamsulosin(0.2 mg/d)for 4 weeks only.After 4 weeks’treatment,the effects were evaluated by the NIH Chronic Prostatitis Symptom Index(NIH-CPSI),and the complications and safety were analyzed.Result:After 4 weeks’treatment,the scores of NIH-CPSI in the two groups significantly reduced,and the improvement of the study group was significantly better than that of the control group.The difference was statistically significant(P<0.05).In addition,the total effective rate of the study group was significantly higher than that of the control group(73.1%vs 34.6%).The difference was statistically significant(P<0.05).Conclusion:Low-energy shock wave therapy combined with tamsulosin is a significant effective treatment for refractory typeⅢB prostatitis,which is significantly better than conventional drug therapy(tamsulosin).It shows that low-energy shock wave therapy can further improve the curative effect of refractory typeⅢB prostatitis with higher safety.Thus,it’s worth popularizing.

关 键 词：低能量冲击波 慢性前列腺炎 ⅢB型前列腺炎 NIH-CPSI评分 治疗 

分 类 号：R697[医药卫生—泌尿科学]